Fred Hutch licenses new immunotherapy treatment to Mustang Bio, preps clinical trials in Seattle – GeekWire
GeekWire |
Fred Hutch licenses new immunotherapy treatment to Mustang Bio, preps clinical trials in Seattle
GeekWire The technology is the basis for a new kind of CAR T immunotherapy treatment, which genetically engineers a patient's immune cells to fight cancer. Similar treatments have been under development at biotech companies across the country for several years, … Mustang Bio Announces Expansion of CAR T Pipeline into CD20-Directed Immunotherapies |
